Skip to main content
Yunkang Group Limited logo

Yunkang Group Limited — Investor Relations & Filings

Ticker · 2325 ISIN · KYG9889T1067 HKEX Human health and social work activities
Open in API
Filings indexed 1,523 across all filing types
Latest filing 2025-04-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2325

About Yunkang Group Limited

http://www.yunkanghealth.com

Yunkang Group Limited is a leading medical operation service platform specializing in standardized medical diagnostic services. The company provides comprehensive clinical diagnostic capabilities to collaborative hospitals and integrated healthcare systems (hospital alliances). Its core business lines include diagnostic testing services and diagnostic outsourcing services for medical institutions, as well as diagnostic testing for non-medical clients. Yunkang leverages a nationwide service network and operates independent clinical laboratories (ICLs) across key regions. These ICLs often hold dual international accreditations, such as ISO15189 and CAP, ensuring high-quality, full-range clinical diagnostic support.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities (for the month ended 31 March 2025)
Regulatory Filings Classification · 87% confidence The document is titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules,” an HKEX‐mandated periodic return detailing movements in authorized share capital, issued shares, warrants, convertibles, etc. It is not a management or earnings report, proxy statement, AGM material, nor is it a notice of dividend or delisting. It is a routine regulatory return under the exchange’s listing rules without a dedicated category in our taxonomy, so it falls under the fallback category for miscellaneous regulatory filings.
2025-04-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2025
Regulatory Filings Classification · 85% confidence The document is a standardized monthly return (Form FF301) submitted to the Hong Kong Stock Exchange under Listing Rule Chapter 19B, detailing movements in authorized/registered share capital and issued shares. It is a routine regulatory compliance filing rather than an earnings release, annual report, share issuance notice, or management announcement. As such, it falls under the general regulatory filings category (fallback).
2025-04-03 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 90% confidence The document provides an overview of the company’s board of directors, their roles, and committee memberships. It does not announce any changes, new appointments, or departures (which would be MANG), but rather describes the board structure and governance framework. This matches the definition for Governance Information (CGR).
2025-04-01 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024' and contains detailed audited consolidated financial results, including comprehensive income statements, financial position statements, notes to the consolidated financial statements, and accounting policies. The content includes full financial data and analysis for the fiscal year ended December 31, 2024, which is characteristic of a full annual report. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or summary. There is no indication that this is merely an announcement of a report or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-03-28 English
CHANGE OF DATE OF BOARD MEETING
Regulatory Filings Classification · 82% confidence The document is a short announcement regarding the rescheduling of the board meeting date for Yunkang Group Limited. It does not present financial results, detailed reports, or changes in board composition, nor is it a notice of dividend, proxy material, or other specific categories. It is a general regulatory announcement on the company’s website (HKEX). Therefore it best fits the fallback category of Regulatory Filings (RNS).
2025-03-20 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 75% confidence The document is a brief announcement by the company on the date of its upcoming Board meeting where it will approve and publish its annual results. It does not contain the results themselves but merely notifies stakeholders of the timing of the report’s publication. This matches the definition of a Report Publication Announcement (RPA).
2025-03-13 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.